GO:0070365 hepatocyte differentiation: Developmental Pathway, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0070365 (hepatocyte differentiation) describes the process by which a relatively unspecialized cell acquires the specialized features of a hepatocyte, the main structural epithelial cell of the liver organized into lobules.
• Hepatocyte differentiation proceeds from definitive endoderm through hepatic specification, hepatoblast formation, and functional maturation, guided by a sequential transcription factor cascade.
• Core transcriptional regulators include FOXA, GATA, HNF4A, HNF1A, HNF6, CEBPA and PROX1, which together establish and maintain the hepatocyte gene expression program.
• Signaling inputs such as Wnt/beta-catenin, FGF, BMP, HGF and oncostatin M cooperate with transcription factors to drive differentiation and maturation.
• MicroRNAs are crucial post-transcriptional players in the differentiation of human pluripotent and multipotent stem cells into functional hepatocyte-like cells.
• Hepatocyte differentiation can be modeled in vitro from mesenchymal stem cells, pluripotent stem cells and liver ductal organoids, and is studied with CRISPR screens, transcriptomics, imaging and functional assays.
Description
GO:0070365, hepatocyte differentiation, is the biological process in which a relatively unspecialized cell acquires the specialized features of a hepatocyte, the main structural epithelial cell of the liver that is organized into interconnected plates called lobules. This process is central to liver development, regeneration and metabolic homeostasis, and it is a foundational topic for developmental biologists, hepatologists and cell engineers. Understanding hepatocyte differentiation is essential because the liver performs hundreds of metabolic, synthetic and detoxifying functions, and loss of the differentiated hepatocyte phenotype underlies many forms of liver disease. The process has been studied for decades, beginning with classical embryological and molecular analyses of endoderm patterning and hepatic specification. More recently, advances in stem cell biology and organoid technology have made it possible to recapitulate hepatocyte differentiation in vitro from pluripotent and multipotent stem cells, enabling disease modeling, drug testing and regenerative medicine applications. This article summarizes the QuickGO definition, the molecular and cellular mechanisms, the key genes and signaling pathways, the links to human disease, and the experimental methods, including CRISPR-based approaches, used to study hepatocyte differentiation.
hepatocyte differentiation At A Glance
| GO ID | GO:0070365 |
|---|---|
| GO term | hepatocyte differentiation |
| Ontology | biological_process |
| Synonym | liver cell differentiation |
| Major function | Acquisition of specialized hepatocyte features by an unspecialized cell, including epithelial organization into lobules and mature liver functions |
| Definition source | QuickGO definition: the process in which a relatively unspecialized cell acquires the specialized features of a hepatocyte |
| Related processes | Endoderm development, hepatic specification, hepatoblast differentiation, epithelial polarization, bile canaliculi formation |
| Key regulators | FOXA, GATA, HNF4A, HNF1A, HNF6, CEBPA, PROX1 and signaling pathways such as Wnt, FGF, BMP, HGF and oncostatin M |
| Research models | Pluripotent stem cells, mesenchymal stem cells, liver ductal organoids, primary hepatocytes and CRISPR-engineered cell lines |
What Is GO:0070365?
According to the Gene Ontology, GO:0070365 (hepatocyte differentiation) is the process in which a relatively unspecialized cell acquires the specialized features of a hepatocyte. A hepatocyte is a specialized epithelial cell that is organized into interconnected plates called lobules and is the main structural component of the liver. The synonym liver cell differentiation is also used for this term. In practical terms, hepatocyte differentiation encompasses the progressive restriction of developmental potential, the activation of a liver-specific transcriptional program, the acquisition of epithelial polarity and bile canalicular structures, and the expression of mature hepatocyte functions such as albumin secretion, urea cycle activity and cytochrome P450-mediated drug metabolism.
Why Is hepatocyte differentiation Important in Cell Biology?
Hepatocyte differentiation is important because it underpins liver development, regeneration and the maintenance of metabolic homeostasis, and because defects in this process contribute to a wide range of human diseases, including congenital liver disorders, metabolic liver disease, hepatitis, cirrhosis and hepatocellular carcinoma. The ability to direct hepatocyte differentiation in vitro from stem cells has opened new avenues for disease modeling, drug toxicity testing and cell-based therapies, and it has become a central goal of regenerative medicine. Moreover, understanding the transcriptional and signaling control of hepatocyte differentiation provides a framework for engineering functional hepatocyte-like cells and for interpreting the effects of genetic variants and CRISPR perturbations in liver biology.
• Hepatocyte differentiation is essential for normal liver development and for the acquisition of mature liver functions such as albumin synthesis, urea cycle activity and drug metabolism.
• Defects in hepatocyte differentiation are linked to congenital and acquired liver diseases, including metabolic disorders, cholestasis and hepatocellular carcinoma.
• The process is a key target for regenerative medicine because functional hepatocytes are needed for cell therapy and bioartificial liver support.
• In vitro hepatocyte differentiation from pluripotent and multipotent stem cells enables disease modeling and drug toxicity screening.
• MicroRNAs and epigenetic regulators modulate hepatocyte differentiation, adding layers of post-transcriptional and chromatin-level control.
• Signaling pathways such as Wnt/beta-catenin, FGF, BMP, HGF and oncostatin M are critical for hepatic specification and maturation.
• Liver ductal organoids can be induced to differentiate into hepatocytes by transducing liver-specific transcription factors, providing a tractable model system.
• Hepatocyte differentiation is accompanied by anisotropic expansion of bile canaliculi, a morphological hallmark of functional polarization.
• CRISPR-based screens and knockout models are increasingly used to identify genes required for hepatocyte differentiation and function.
• Understanding hepatocyte differentiation informs efforts to generate hepatocyte-like cells for transplantation and to study liver-specific drug metabolism.
What Happens During hepatocyte differentiation?
Definitive endoderm and hepatic specification
In simple terms: The first step is that early embryonic cells are instructed to become the tissue that will form the liver.
Hepatocyte differentiation begins during embryogenesis when cells of the definitive endoderm are patterned to adopt a hepatic fate. This specification step depends on inductive signals from adjacent mesoderm, including FGF and BMP family ligands, which activate a hepatic gene regulatory network in the ventral foregut endoderm. The transcription factors FOXA and GATA family members act as pioneer factors that open chromatin at liver-specific enhancers and initiate the hepatic program. Disruption of these early events prevents formation of the liver bud and blocks subsequent hepatocyte differentiation.
Hepatoblast formation and differentiation
In simple terms: The specified cells multiply and become hepatoblasts, the bipotential progenitors that can become either hepatocytes or bile duct cells.
After specification, the hepatic endoderm gives rise to hepatoblasts, which are bipotential progenitor cells capable of differentiating into both hepatocytes and cholangiocytes. Hepatoblast proliferation and survival are supported by growth factors such as HGF and by signaling through the Wnt/beta-catenin pathway. The transcription factor PROX1 and members of the HNF family help maintain the hepatoblast state and repress alternative fates. Lineage-tracing and organoid studies have shown that hepatoblasts can be expanded in culture and then induced to differentiate into functional hepatocytes.
Transcriptional maturation of hepatocytes
In simple terms: A set of master transcription factors switches on the genes that make a liver cell a liver cell.
Terminal hepatocyte differentiation is driven by a core network of transcription factors, including HNF4A, HNF1A, HNF6, CEBPA and FOXA family members, which together activate hepatocyte-specific genes such as ALB, APOA1, TTR and cytochrome P450 enzymes. This network also represses progenitor and non-hepatic genes, locking in the differentiated state. The transcriptional control of hepatocyte differentiation is reinforced by epigenetic changes, including DNA methylation and histone modifications, that stabilize the mature expression profile. MicroRNAs such as miR-122 and other liver-enriched species further fine-tune the differentiation program at the post-transcriptional level.
Epithelial polarization and bile canaliculi formation
In simple terms: The new liver cells organize themselves into polarized sheets with tiny channels for bile, which is a sign they are truly mature.
As hepatocytes mature, they acquire a polarized epithelial architecture with apical and basolateral domains, and they form bile canaliculi between adjacent cells. Live imaging in developing liver has shown that hepatocyte differentiation requires anisotropic expansion of bile canaliculi, a process that depends on coordinated cytoskeletal and junctional remodeling. This morphological maturation is essential for bile secretion and for the overall organization of hepatocytes into interconnected plates called lobules. Defects in polarization and canalicular expansion impair liver function and are associated with cholestatic disease.
Metabolic and functional maturation
In simple terms: The cells finally become fully functional liver cells that can make proteins, process drugs and handle waste.
Functional maturation of hepatocytes involves the induction of metabolic pathways such as the urea cycle, gluconeogenesis, lipid metabolism and phase I and phase II drug metabolism. Maturation is promoted by hormones and cytokines, including oncostatin M, dexamethasone and HGF, which activate signaling cascades that cooperate with the transcriptional network. In vitro differentiation protocols typically assess maturation by measuring albumin secretion, urea production, cytochrome P450 activity and glycogen storage. Single-cell and bulk transcriptomic studies have revealed that maturation is a gradual process with intermediate states, and that full functional maturity may require additional cues such as three-dimensional culture or co-culture with non-parenchymal cells.
Key Genes Involved in GO:0070365 hepatocyte differentiation
The following genes and proteins are central to hepatocyte differentiation, based on published studies of hepatic specification, transcriptional control and in vitro differentiation.
| Gene | Major Role | Research Relevance |
|---|---|---|
| FOXA1 | Pioneer transcription factor that opens chromatin at hepatic enhancers and initiates the hepatic program | Knockout and knockdown studies define its role in endoderm patterning and hepatocyte specification |
| FOXA2 | Pioneer factor cooperating with FOXA1 in hepatic specification and maintenance of hepatocyte identity | CRISPR knockout models reveal redundancy and stage-specific requirements |
| GATA4 | Endodermal transcription factor that promotes hepatic competence and cooperates with FOXA factors | Used to study early hepatic specification and chromatin remodeling |
| GATA6 | Transcription factor involved in foregut endoderm patterning and hepatic gene activation | Knockout and overexpression models assess its role in hepatocyte differentiation |
| HNF4A | Master regulator of hepatocyte differentiation and maintenance of the mature hepatocyte phenotype | Central target for knockout, point mutation and rescue experiments in hepatocyte models |
| HNF1A | Transcription factor that activates hepatocyte-specific genes and supports metabolic maturation | Mutations are studied in maturity-onset diabetes of the young and liver disease models |
| HNF6 | Regulator of hepatocyte and cholangiocyte differentiation and bile duct development | Knockout models show defects in liver architecture and differentiation |
| CEBPA | Transcription factor that cooperates with HNF4A to drive hepatocyte gene expression | Used in reprogramming and differentiation studies of hepatocyte-like cells |
| PROX1 | Maintains the hepatoblast state and regulates hepatocyte proliferation and differentiation | Lineage tracing and knockout studies define its role in liver development |
| ALB | Albumin, a marker of mature hepatocyte function and the most abundant secreted liver protein | Used as a readout of hepatocyte differentiation in vitro and in vivo |
| APOA1 | Apolipoprotein A1, a hepatocyte-secreted protein involved in lipid transport | Marker of functional hepatocyte maturation in differentiation protocols |
| TTR | Transthyretin, a secreted protein produced by mature hepatocytes | Common marker for assessing hepatocyte differentiation efficiency |
| CYP3A4 | Cytochrome P450 enzyme responsible for drug metabolism in mature hepatocytes | Functional marker for drug metabolism studies and toxicity testing |
| CYP1A2 | Cytochrome P450 enzyme involved in xenobiotic metabolism | Used to evaluate metabolic maturation of hepatocyte-like cells |
| ASGR1 | Asialoglycoprotein receptor 1, a surface marker of mature hepatocytes | Used for purification and characterization of differentiated hepatocytes |
| AFP | Alpha-fetoprotein, a fetal hepatocyte marker that declines with maturation | Used to distinguish fetal and mature hepatocyte states in differentiation studies |
| KRT19 | Cytokeratin 19, a marker of cholangiocytes and bipotent progenitors | Helps assess lineage specification and hepatocyte versus cholangiocyte fate |
| MIR122 | Liver-enriched microRNA that promotes and maintains the hepatocyte phenotype | Studied for its role in differentiation and liver disease |
How Is hepatocyte differentiation Regulated?
Hepatocyte differentiation is regulated at multiple levels. Extracellular signals, including Wnt/beta-catenin, FGF, BMP, HGF and oncostatin M, activate intracellular cascades that cooperate with the core transcription factor network to drive hepatic specification and maturation. Transcription factors such as FOXA, GATA, HNF4A, HNF1A, HNF6, CEBPA and PROX1 form a hierarchical and mutually reinforcing network that establishes and maintains the hepatocyte gene expression program. Epigenetic mechanisms, including chromatin remodeling, histone modification and DNA methylation, stabilize the differentiated state and restrict alternative fates. MicroRNAs, notably liver-enriched species such as miR-122, provide post-transcriptional regulation of the differentiation program and can influence the efficiency of in vitro differentiation of pluripotent and multipotent stem cells into hepatocyte-like cells. In addition, cell-cell and cell-matrix interactions, as well as mechanical cues associated with bile canaliculi expansion, contribute to the morphological and functional maturation of hepatocytes.
hepatocyte differentiation and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| HNF1A | Maturity-onset diabetes of the young and metabolic liver dysfunction | Knockout and point-mutation hepatocyte-like cells differentiated from pluripotent stem cells |
| HNF4A | Liver metabolic disorders and hepatocellular carcinoma | Knockout, knockdown and rescue experiments in hepatocyte differentiation cultures |
| PROX1 | Liver development defects and altered hepatocyte proliferation | Lineage tracing and conditional knockout in liver organoids |
| MIR122 | Liver disease and impaired hepatocyte differentiation | Overexpression and knockout of miR-122 in stem cell-derived hepatocyte-like cells |
| KRT19 | Cholangiocyte fate and biliary disease | Knockout and lineage-tracing models in liver ductal organoids |
Hepatocyte differentiation defects in liver disease
Disruption of hepatocyte differentiation contributes to a range of liver disorders, including congenital hepatic malformations, metabolic liver diseases and cholestatic conditions. Mutations in transcription factors such as HNF1A and HNF4A impair hepatocyte function and have been linked to maturity-onset diabetes of the young and other metabolic phenotypes. Defects in epithelial polarization and bile canaliculi formation can lead to cholestasis and impaired bile flow. Understanding these defects provides a rationale for developing differentiation-based therapies and for modeling liver disease in vitro.
Hepatocellular carcinoma and dedifferentiation
Loss of the differentiated hepatocyte phenotype is a hallmark of hepatocellular carcinoma, in which tumor cells often display progenitor-like features and reduced expression of mature hepatocyte genes. The transcriptional network that drives hepatocyte differentiation, including HNF4A and CEBPA, is frequently dysregulated in liver cancer, and restoring differentiation-associated programs can suppress tumorigenic properties in experimental models. Studying hepatocyte differentiation therefore provides insights into the mechanisms of liver cancer development and potential differentiation-based therapeutic strategies.
Stem cell-based modeling of hepatocyte differentiation
Human pluripotent and multipotent stem cells can be directed to differentiate into hepatocyte-like cells, providing a platform for modeling genetic liver diseases and for drug toxicity testing. MicroRNAs are crucial players in this process, and manipulating their activity can improve the efficiency and fidelity of hepatocyte differentiation. Liver ductal organoids can also be induced to differentiate into hepatocytes by transducing liver-specific transcription factors, offering a complementary model system for studying differentiation and disease. These stem cell-based models are increasingly combined with CRISPR genome editing to dissect gene function in human liver biology.
From hepatocyte differentiation-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Is a candidate gene required for hepatocyte differentiation? | CRISPR knockout in pluripotent stem cells or liver organoids followed by differentiation and marker analysis |
| Does a specific point mutation affect hepatocyte maturation? | Point-mutation knock-in in a hepatocyte differentiation cell model with functional readouts |
| Can a transcription factor drive hepatocyte differentiation? | Overexpression or inducible knock-in of liver-specific transcription factors in ductal organoids or stem cells |
| How does a gene affect bile canaliculi formation? | Tagged knock-in of junctional or cytoskeletal proteins combined with live imaging in differentiating hepatocytes |
| What is the role of a microRNA in hepatocyte differentiation? | Overexpression or knockout of the microRNA in pluripotent stem cell-derived hepatocyte-like cells |
| Which genes are essential for metabolic maturation? | CRISPR library screening in differentiating hepatocyte cultures with metabolic and transcriptomic readouts |
How to Study the hepatocyte differentiation Process
| Method | What It Measures | Typical Application |
|---|---|---|
| RNA sequencing | Global transcriptome changes during differentiation | Comparing differentiation stages and protocols |
| Single-cell RNA sequencing | Cell-to-cell heterogeneity and intermediate states | Resolving subpopulations in stem cell-derived hepatocyte cultures |
| Albumin secretion assay | Functional maturation of hepatocytes | Validating differentiation efficiency and CRISPR perturbations |
| Urea production assay | Metabolic maturation and nitrogen metabolism | Assessing functional hepatocyte differentiation |
| CYP450 activity assay | Drug-metabolizing enzyme function | Toxicity testing and metabolic maturation studies |
| Live imaging of bile canaliculi | Epithelial polarization and canalicular dynamics | Studying morphological maturation during differentiation |
| Immunostaining | Expression and localization of hepatocyte markers | Characterizing differentiated cells and organoids |
| CRISPR knockout screening | Genes required for or restricting differentiation | Identifying regulators of hepatocyte differentiation |
Transcriptomic and single-cell analysis
RNA sequencing and single-cell RNA sequencing are widely used to profile the transcriptome during hepatocyte differentiation, revealing stage-specific gene expression programs and intermediate cell states. These methods allow researchers to compare differentiation protocols, identify markers of maturation and detect off-target lineage fates. Single-cell approaches are particularly valuable for resolving heterogeneity in stem cell-derived hepatocyte cultures.
Functional and metabolic assays
Functional maturation of hepatocytes is assessed by measuring albumin secretion, urea production, glycogen storage and cytochrome P450 activity. These assays provide quantitative readouts of hepatocyte differentiation and are essential for validating differentiation protocols and CRISPR perturbations. Drug metabolism and toxicity assays using differentiated hepatocyte-like cells are commonly used in pharmacology and toxicology.
Imaging and morphological analysis
Live imaging and high-resolution microscopy are used to study the morphological changes that accompany hepatocyte differentiation, including epithelial polarization and bile canaliculi formation. Anisotropic expansion of bile canaliculi can be visualized with fluorescent markers and time-lapse imaging in developing liver and in vitro models. Immunostaining for hepatocyte markers such as ALB, HNF4A and ASGR1 complements morphological analyses.
CRISPR screening and gene editing
CRISPR knockout, point mutation, knock-in and overexpression approaches are used to test the function of candidate genes in hepatocyte differentiation. Pooled CRISPR screens can identify genes that promote or inhibit differentiation when combined with selection or sorting based on hepatocyte markers. Liver ductal organoids transduced with liver-specific transcription factors provide a complementary system for gain-of-function studies.
How CRISPR Can Be Used to Study GO:0070365 hepatocyte differentiation
Knockout
CRISPR knockout is used to delete candidate genes in pluripotent stem cells, liver organoids or hepatocyte-like cells and then assess the consequences for hepatocyte differentiation. Knockout of transcription factors such as HNF4A or HNF1A impairs the expression of mature hepatocyte markers and provides direct evidence of their requirement. Pooled knockout screens can systematically identify genes that are essential for differentiation or that restrict it.
Point Mutation
Point-mutation knock-in allows researchers to model disease-associated variants in genes involved in hepatocyte differentiation, such as HNF1A and HNF4A. By introducing a specific amino acid change, it is possible to separate the effects of a variant from complete loss of function and to study dominant-negative or gain-of-function mechanisms. These models are valuable for understanding how genetic variants contribute to liver disease and metabolic disorders.
Knock-in
Knock-in of reporter genes, tags or inducible cassettes enables precise tracking of hepatocyte differentiation in real time. For example, tagging junctional or cytoskeletal proteins allows live imaging of bile canaliculi formation during differentiation. Knock-in of liver-specific transcription factors under inducible promoters can drive differentiation of ductal organoids or stem cells into hepatocytes.
Overexpression
Overexpression of transcription factors or microRNAs can promote or enhance hepatocyte differentiation in vitro. Transducing liver-specific transcription factors into mouse liver ductal organoids induces hepatocyte differentiation, demonstrating the power of gain-of-function approaches. Overexpression of microRNAs such as miR-122 can improve the efficiency of generating functional hepatocyte-like cells from pluripotent stem cells.
How EDITGENE Supports hepatocyte differentiation Research
Researchers studying hepatocyte differentiation-related genes often need to determine whether a candidate gene is causally involved in the process, how a specific disease variant affects hepatocyte function, or whether a gene can be used to improve differentiation efficiency. Answering these questions requires precise, reproducible genome engineering in relevant cell models, combined with functional and transcriptomic readouts. EDITGENE provides a comprehensive suite of CRISPR-based services tailored to hepatocyte differentiation research, from knockout and point-mutation models to knock-in reporters, overexpression systems, library screening and bioinformatics support.
Contact EDITGENE today to design your custom CRISPR model for hepatocyte differentiation research.
Frequently Asked Questions About hepatocyte differentiation
What is GO:0070365 hepatocyte differentiation?
GO:0070365 is the Gene Ontology biological process term for hepatocyte differentiation, defined as the process in which a relatively unspecialized cell acquires the specialized features of a hepatocyte, the main structural epithelial cell of the liver organized into lobules.
What genes are involved in hepatocyte differentiation?
Key genes include FOXA1, FOXA2, GATA4, GATA6, HNF4A, HNF1A, HNF6, CEBPA, PROX1, ALB, APOA1, TTR, CYP3A4, CYP1A2, ASGR1, AFP, KRT19 and MIR122, which together control hepatic specification, maturation and function.
What are the main stages of hepatocyte differentiation?
The main stages are definitive endoderm formation, hepatic specification, hepatoblast formation, transcriptional maturation, epithelial polarization with bile canaliculi formation, and metabolic and functional maturation.
How is hepatocyte differentiation regulated?
It is regulated by signaling pathways such as Wnt/beta-catenin, FGF, BMP, HGF and oncostatin M, by a core transcription factor network including HNF4A and HNF1A, by epigenetic mechanisms and by microRNAs such as miR-122.
Why is hepatocyte differentiation important for liver disease?
Defects in hepatocyte differentiation contribute to congenital liver disorders, metabolic liver disease, cholestasis and hepatocellular carcinoma, and loss of the differentiated phenotype is a hallmark of liver cancer.
Can stem cells be differentiated into hepatocytes?
Yes, human pluripotent and multipotent stem cells can be directed to differentiate into functional hepatocyte-like cells, and microRNAs are crucial players in this process.
What methods are used to study hepatocyte differentiation?
Common methods include RNA sequencing, single-cell RNA sequencing, albumin and urea assays, cytochrome P450 activity assays, live imaging of bile canaliculi, immunostaining and CRISPR screening.
How are CRISPR models used in hepatocyte differentiation research?
CRISPR knockout, point mutation, knock-in and overexpression models are used to test gene function, model disease variants, track differentiation with reporters and identify regulators through pooled screens.
What is the role of bile canaliculi in hepatocyte differentiation?
Bile canaliculi are apical channels that form between adjacent hepatocytes during differentiation, and their anisotropic expansion is required for proper hepatocyte polarization and liver function.
Which transcription factors are considered master regulators of hepatocyte differentiation?
HNF4A, HNF1A, HNF6, CEBPA and FOXA family members are considered core regulators that establish and maintain the hepatocyte gene expression program.
Conclusion
GO:0070365 hepatocyte differentiation is a fundamental developmental process that transforms unspecialized cells into functional hepatocytes, the main epithelial cells of the liver. It is controlled by a hierarchical network of transcription factors, signaling pathways, epigenetic regulators and microRNAs, and it culminates in epithelial polarization, bile canaliculi formation and metabolic maturation. Because defects in hepatocyte differentiation underlie many liver diseases and because functional hepatocytes are needed for regenerative medicine and drug testing, this process is a major focus of biomedical research. Advances in stem cell biology, organoid technology and CRISPR genome editing are accelerating the discovery of new regulators and the development of improved differentiation protocols, with the ultimate goal of generating functional hepatocytes for therapy and disease modeling.
References
- 1. Bebelman MP et al.. 2024. Hepatocyte differentiation requires anisotropic expansion of bile canaliculi.. Development 151(22) PMID: 39373104
- 2. Wu XB et al.. 2012. Hepatocyte differentiation of mesenchymal stem cells.. Hepatobiliary Pancreat Dis Int 11(4):360-71 PMID: 22893462
- 3. Olsavsky Goyak KM et al.. 2010. Hepatocyte differentiation.. Methods Mol Biol 640:115-38 PMID: 20645049
- 4. Zaret KS. 2001. Hepatocyte differentiation: from the endoderm and beyond.. Curr Opin Genet Dev 11(5):568-74 PMID: 11532400
- 5. Tomofuji K et al.. 2023. Hepatocyte differentiation from mouse liver ductal organoids by transducing 4 liver-specific transcription factors.. Hepatol Commun 7(5) PMID: 37058099
- 6. Vasconcellos R et al.. 2016. Exploring the cell signalling in hepatocyte differentiation.. Cell Signal 28(11):1773-88 PMID: 27555287
- 7. Nagaoka M et al.. 2010. Transcriptional control of hepatocyte differentiation.. Prog Mol Biol Transl Sci 97:79-101 PMID: 21074730
- 8. Xu H et al.. 2022. MicroRNAs: Crucial Players in the Differentiation of Human Pluripotent and Multipotent Stem Cells into Functional Hepatocyte-Like Cells.. Curr Stem Cell Res Ther 17(8):734-740 PMID: 34615452
